Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.47
-7.02 (-56.20%)
At close: Mar 2, 2026, 4:00 PM EST
5.51
+0.04 (0.73%)
After-hours: Mar 2, 2026, 7:59 PM EST
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $119.1 million as of March 2, 2026.
Market Cap
119.10M
Enterprise Value
-6.71M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.47
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $119.10M, a decrease of -65.19%. That is a compound annual growth rate of -63.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 271.95M | -4.84% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 130.45M |
| Genelux | 126.21M |
| Cardiff Oncology | 125.79M |
| MacroGenics | 122.72M |
| Spero Therapeutics | 121.69M |
| Tenaya Therapeutics | 119.08M |
| Inovio Pharmaceuticals | 116.80M |
| Turn Therapeutics | 113.07M |